DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo



199.38 5.44 (2.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACT $199.38 2.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $197.39
Previous Close $193.94
Daily Range $195.00 - $200.51
52-Week Range $96.15 - $230.77
Market Cap $34.7B
P/E Ratio -36.80
Dividend (Yield) $0.00 (0.0%)
Volume 2,892,527
Average Daily Volume 2,907,195
Current FY EPS $13.03





ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website:

News & Commentary

Is This Drug Maker’s Stock Too Cheap to Ignore?

Teva Pharmaceutical shares have under performed its sector over the past year. Though the company faces a number of issues, most of the bad news may already be priced into the stock. Given the drug maker also appears to have some intriguing opportunities for future growth, are Teva shares too cheap to ignore?

Sterne Agee Sees 16% Upside for Actavis, Initiates Coverage

Mylan Inks Two Separate Agreements - Analyst Blog

Benzinga's Top Initiations

Acura Pharma Ends Agreement with Pfizer - Analyst Blog

Acura Pharma Ends Agreement with Pfizer - Analyst Blog

3 Health Care Stocks Moving The Sector Upward

Regulatory Update from Forest Labs - Analyst Blog

Regulatory Update from Forest Labs - Analyst Blog

Actavis Becomes #157 Most Shorted S&P 500 Component, Replacing Vornado Realty Trust

Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick

S&P 500 Movers: ISRG, ACT

Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape

See More ACT News...

ACT's Top Competitors

ACT $199.38 (2.80%)
Current stock: ACT
JNJ $98.75 (-0.45%)
Current stock: JNJ
NVS $84.41 (0.74%)
Current stock: NVS
RHHBY $36.17 (0.08%)
Current stock: RHHBY